Watch IDXG. Know when insiders buy.
One email the day a filing lands. Free.
IDXG
INTERPACE BIOSCIENCES, INC.
6.51
−0.47 −6.73%
USD · close Sep 3
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $180.3MP/E 7.3DIV YIELD —FCF YIELD 2.28%REV TTM $36.1M −20.5%NET INCOME $24.4M +435.6%NET CASH $940K52W 1.52 – 7.62SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $9.1M | −1.1% | 61.9% | $321K | $158K | — | 0.01 | $98K | $57K | $41K | Aug 10 |
| Q1 2026 · Mar 31 | $9M | −21.6% | 65.4% | $1.1M | $721K | −56.2% | 0.03 | $283K | $141K | $142K | Aug 10 |
| Q4 2025 · Dec 31derived | $9.2M | −25.7% | 65.5% | $1.6M | $22.7M | +1104.5% | 0.82 | $2.1M | $38K | $2.1M | Mar 30 |
| Q3 2025 · Sep 30 | $8.8M | −28.8% | 62.1% | $1.1M | $911K | −45.6% | 0.03 | $1.9M | $117K | $1.8M | Nov 12 |
| Q2 2025 · Jun 30 | $9.2M | −23.3% | 57.1% | −$468K | −$640K | −126.3% | -0.14 | $520K | — | — | Aug 10 |
| Q1 2025 · Mar 31 | $11.5M | +13.1% | 64.0% | $1.8M | $1.6M | +132.6% | 0.06 | $1.2M | — | — | Aug 10 |
| Q4 2024 · Dec 31derived | $12.4M | +22.5% | 63.7% | $2.1M | $1.9M | +76.3% | -0.69 | $1.2M | $129K | $1.1M | Mar 30 |
| Q3 2024 · Sep 30 | $12.3M | +33.6% | 64.3% | $2.3M | $1.7M | — | 0.38 | $2.1M | $522K | $1.6M | Nov 12 |
| Q2 2024 · Jun 30 | $12M | — | 64.8% | $2.6M | $2.4M | — | 0.55 | $1.4M | $197K | $1.2M | Nov 12 |
| Q1 2024 · Mar 31 | $10.2M | — | 62.0% | $1.1M | $708K | — | 0.16 | −$58K | $28K | −$86K | Nov 12 |
| Q4 2023 · Dec 31derived | $10.1M | — | 62.3% | $1.5M | $1.1M | — | 0.25 | $1.1M | $142K | $998K | Mar 31 |
| Q3 2023 · Sep 30 | $9.2M | — | 58.5% | $412K | −$186K | — | -0.04 | $1.1M | $152K | $953K | Mar 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $38.7M | 62.3% | $4.1M | $24.6M | 63.5% | 0.89 | $5.8M | $356K | $5.5M | — | — |
| FY2024 · to Dec 31 | $46.9M | 63.8% | $8.1M | $6.7M | 14.3% | 0.40 | $4.6M | $876K | $3.8M | — | — |
| FY2023 · to Dec 31 | $40M | 62.6% | $4M | $2M | 4.9% | 0.45 | $3.8M | $470K | $3.3M | — | — |
| FY2022 · to Dec 31 | $5.7M | 321.1% | −$3.6M | −$22M | -386.7% | -5.18 | −$7.7M | $322K | −$8M | — | — |
| FY2021 · to Dec 31 | $8.2M | 229.4% | −$6.3M | −$14.9M | -182.3% | -3.61 | −$8.7M | $354K | −$9.1M | — | — |
| FY2020 · to Dec 31 | $32.4M | 33.1% | −$26.1M | −$26.5M | -81.6% | -7.32 | −$14M | $1.6M | −$15.6M | — | — |
Every number comes from INTERPACE BIOSCIENCES, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.